Skip to main content
logo
Dezhan Healthcare Company Limited (SHE:000813)
China flag China · Delayed Price · Currency is CNY
3.030
+0.010 (0.33%)
Oct 23, 2026, 3:04 PM CST

Dezhan Healthcare Company Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
373.09396.81466.49498.09570.86734.48
Revenue Growth
-2.97%-14.94%-6.35%-12.75%-22.28%-23.72%
Gross Profit
169.91211.23296.09274.96211.41473.06
Operating Income
-229.62-182.03-80.67-55.69-153.149.77
Net Income
-360.69-345.42-20.4183.31-46.95-57.58
Earnings Per Share
-0.17-0.16-0.010.04-0.02-0.03
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Business Segment
394.03463.89489.24562.19703.17
Other Business Segments
1.010.50.70.230.03
Peptides
1.772.095.884.857.09
Total
396.81466.49498.09570.86734.48

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,3481,8162,5312,7962,9992,492
Total Debt
131.32134.7818.137.579.0712.36
Net Cash (Debt)
1,2171,6812,5132,7892,9902,480
Net Cash Growth
-47.47%-33.10%-9.91%-6.73%20.58%-29.44%
Net Cash Per Share
0.580.791.171.281.351.11

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-75.374.72-14.59127.87161.7242.41
Capital Expenditures
-251.59-235.99-166.55-159.73-67.56-126.92
Free Cash Flow
-326.97-231.27-181.14-31.8694.16-84.51
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
45.54%53.23%63.47%55.20%37.04%64.41%
Operating Margin
-61.55%-45.87%-17.29%-11.18%-26.82%6.78%
Pretax Margin
-116.50%-105.95%-9.46%16.43%-21.21%-5.05%
Profit Margin
-96.68%-87.05%-4.38%16.73%-8.22%-7.84%
FCF Margin
-87.64%-58.28%-38.83%-6.40%16.50%-11.51%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---84.57--
Forward PE
-25.9625.9625.9625.9625.96
P/FCF Ratio
----87.40-
PS Ratio
17.0320.2914.5314.1514.4212.29